GFS Advisors’s Sanofi SNY Stock Holding History

GFS Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$323K	Sell	6,700 -3,300	-33%	-$154K	0.04%	139
2025 Q4	$485K	Hold	10,000	–	–	0.06%	132
2025 Q3	$472K	Hold	10,000	–	–	0.06%	123
2025 Q2	$483K	Hold	10,000	–	–	0.07%	115
2025 Q1	$555K	Sell	10,000 -2,800	-22%	-$152K	0.11%	91
2024 Q4	$617K	Hold	12,800	–	–	0.09%	101
2024 Q3	$738K	Buy	12,800 +11,655	+1,018%	+$629K	0.16%	75
2024 Q2	$621K	Sell	1,145 -11,655	-91%	-$562K	0.1%	104
2024 Q1	$622K	Sell	12,800 -4,550	-26%	-$222K	0.1%	101
2023 Q4	$863K	Hold	17,350	–	–	0.13%	97
2023 Q3	$931K	Hold	17,350	–	–	0.14%	90
2023 Q2	$935K	Hold	17,350	–	–	0.21%	82
2023 Q1	$944K	Hold	17,350	–	–	0.22%	79
2022 Q4	$840K	Hold	17,350	–	–	0.19%	78
2022 Q3	$660K	Hold	17,350	–	–	0.16%	86
2022 Q2	$868K	Sell	17,350 -3,700	-18%	-$196K	0.19%	77
2022 Q1	$1.08M	Hold	21,050	–	–	0.23%	74
2021 Q4	$1.05M	Sell	21,050 -7,575	-26%	-$375K	0.17%	87
2021 Q3	$1.38M	Hold	28,625	–	–	0.3%	75
2021 Q2	$1.51M	Hold	28,625	–	–	0.34%	64
2021 Q1	$1.42M	Sell	28,625 -4,550	-14%	-$219K	0.33%	61
2020 Q4	$1.61M	Hold	33,175	–	–	0.42%	49
2020 Q3	$1.66M	Sell	33,175 -1,925	-5%	-$99.1K	0.51%	45
2020 Q2	$1.79M	Hold	35,100	–	–	0.55%	45
2020 Q1	$1.53M	Sell	35,100 -575	-2%	-$27.5K	0.48%	46
2019 Q4	$1.79M	Hold	35,675	–	–	0.47%	54
2019 Q3	$1.65M	Sell	35,675 -5,070	-12%	-$219K	0.46%	52
2019 Q2	$1.76M	Sell	40,745 -930	-2%	-$39.5K	0.5%	48
2019 Q1	$1.84M	Sell	41,675 -4,575	-10%	-$196K	0.55%	44
2018 Q4	$2.01M	Sell	46,250 -31,525	-41%	-$1.39M	0.54%	42
2018 Q3	$3.47M	Sell	77,775 -4,820	-6%	-$206K	0.89%	32
2018 Q2	$3.31M	Sell	82,595 -2,700	-3%	-$106K	0.69%	37
2018 Q1	$3.42M	Buy	85,295 +17,725	+26%	+$738K	0.71%	36
2017 Q4	$2.91M	Buy	67,570 +670	+1%	+$30.9K	0.63%	40
2017 Q3	$3.33M	Hold	66,900	–	–	0.75%	33
2017 Q2	$3.21M	Hold	66,900	–	–	0.7%	37
2017 Q1	$3.03M	Buy	66,900 +7,400	+12%	+$314K	0.62%	42
2016 Q4	$2.41M	Buy	59,500 +400	+0.7%	+$15.8K	0.51%	43
2016 Q3	$2.26M	Buy	59,100 +22,150	+60%	+$889K	0.5%	50
2016 Q2	$1.55M	Buy	36,950 +9,600	+35%	+$394K	0.37%	66
2016 Q1	$1.1M	Buy	27,350 +6,350	+30%	+$255K	0.29%	69
2015 Q4	$896K	Buy	21,000 +3,400	+19%	+$156K	0.27%	78
2015 Q3	$835K	Sell	17,600 -500	-3%	-$25.5K	0.29%	78
2015 Q2	$896K	Buy	18,100 +2,550	+16%	+$129K	0.3%	73
2015 Q1	$769K	Sell	15,550 -52,800	-77%	-$2.52M	0.27%	80
2014 Q4	$3.12M	Buy	68,350 +54,250	+385%	+$2.63M	1.24%	26
2014 Q3	$796K	Hold	14,100	–	–	0.33%	73
2014 Q2	$750K	Sell	14,100 -4,005	-22%	-$213K	0.31%	73
2014 Q1	$946K	Buy	18,105 +7,605	+72%	+$385K	0.37%	66
2013 Q4	$563K	Buy	10,500 +2,200	+27%	+$114K	0.28%	74
2013 Q3	$420K	Buy	+8,300	New	+$422K	0.22%	85

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

GFS Advisors's SNY Position: Q1 2026 in Review

GFS Advisors reduced its Sanofi (SNY) stake by 33% in Q1 2026, selling an estimated $154K and leaving 6,700 shares worth $323K. The position accounts for 0.04% of the portfolio, ranked #139.

GFS Advisors first reported a position in SNY in Q3 2013 and has held it in 51 quarters since. The position peaked at $3.47M in Q3 2018. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

GFS Advisors held 6,700 shares of Sanofi worth $323K as of Q1 2026.
GFS Advisors sold 3,300 Sanofi shares in Q1 2026, an estimated $154K.
Sanofi made up 0.04% of GFS Advisors's portfolio in Q1 2026, its #139 holding.
GFS Advisors first reported a position in Sanofi in Q3 2013 and has held it in 51 quarters since.
GFS Advisors's Sanofi position peaked at $3.47M in Q3 2018.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on GFS Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.